Evidence map›Paper›PMID 34933890›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2022

Effects of Tracer Uptake Time in Non-Small Cell Lung Cancer

Guilherme D Kolinger, David Vállez García, Gerbrand Maria Kramer, Virginie Frings, Gerben J C Zwezerijnen, Egbert F Smit, Adrianus Johannes de Langen, Irène Buvat, Ronald Boellaard

Abstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Development and validation of anAnnals of nuclear medicine · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Preclinical and first-in-human evaluation ofEuropean journal of nuclear medicine and molecular imaging · 2022
    Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Guilherme D KolingerMedical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; g.domingues.kolinger@umcg.nl.
David Vállez GarcíaMedical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Gerbrand Maria KramerDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center, VU Medical Center, Amsterdam, The Netherlands.
Virginie FringsDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center, VU Medical Center, Amsterdam, The Netherlands.
Gerben J C ZwezerijnenDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center, VU Medical Center, Amsterdam, The Netherlands.
Egbert F SmitDepartment of Pulmonology, Amsterdam University Medical Center, VU Medical Center, Amsterdam, The Netherlands.
Adrianus Johannes de LangenDepartment of Thoracic Oncology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; and.
Irène BuvatLaboratoire d'Imagerie Translationnelle en Oncologie, INSERM, Institut Curie, Université Paris-Saclay, Orsay, France.
Ronald BoellaardMedical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PET radiomics applied to oncology allow the measurement of intratumoral heterogeneity. This quantification can be affected by image protocols; hence, there is an increased interest in understanding how radiomic expression on PET images is affected by different imaging conditions. To address that interest, this study explored how radiomic features are affected by changes in

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsCross-Sectional StudiesFluorodeoxyglucose F18HumansImage Processing, Computer-AssistedFluorodeoxyglucose F18dual-time-pointPETradiomicsrepeatabilitytexture analysis

Identifiers

PMID34933890
PMCPMC9157719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.